Search research articles
Contact Us
Filters
Showing results (51-60 of 280) with videos related to
Page
of 28
Sort By:
Salud Publica De Mexico
|
January 22, 2015
Breast cancer in Latin America: global burden, patterns, and risk factors
Amina Amadou, Gabriela Torres-Mejía, Pierre Hainaut, et al.
The Lancet. Oncology
|
September 1, 2009
Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening?
Maria Isabel Waddington Achatz, Pierre Hainaut, Patricia Ashton-Prolla
Breast Cancer Research and Treatment
|
March 12, 2010
Estrogen levels act as a rheostat on p53 levels and modulate p53-dependent responses in breast cancer cell lines
Lynnette Fernández-Cuesta, Suresh Anaganti, Pierre Hainaut, et al.
Biochemical Pharmacology
|
March 29, 2003
Activation of p53 by the cytoprotective aminothiol WR1065: DNA-damage-independent pathway and redox-dependent modulation of p53 DNA-binding activity
Olivier Pluquet, Sophie North, Marie-Jeanne Richard, et al.
International Journal of Cancer
|
June 16, 2010
p53 status influences response to tamoxifen but not to fulvestrant in breast cancer cell lines
Lynnette Fernandez-Cuesta, Suresh Anaganti, Pierre Hainaut, et al.
Cancer Letters
|
August 18, 2009
Worldwide genetic diversity of HBV genotypes and risk of hepatocellular carcinoma
Flor Helene Pujol, Maria-Cristina Navas, Pierre Hainaut, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 16, 2010
The European Prospective Investigation into Cancer and Nutrition biobank
Pierre Hainaut, Béatrice Vozar, Sabina Rinaldi, et al.
Gastroenterology
|
June 16, 2009
In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure
Ahmad Besaratinia, Sang-In Kim, Pierre Hainaut, et al.
Cell Death and Differentiation
|
November 24, 2023
Exploring the genetic and molecular basis of differences in multiple myeloma of individuals of African and European descent
Arnold J Levine, John D Carpten, Maureen Murphy, et al.
BMC Cancer
|
March 22, 2013
Effects of Δ40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53
Hind Hafsi, Daniela Santos-Silva, Stéphanie Courtois-Cox, et al.
Page
of 28
Search research articles
Search
Showing results (51-60 of 280) with videos related to
Sort By:
Page
of 28
Salud Publica De Mexico
|
January 22, 2015
Breast cancer in Latin America: global burden, patterns, and risk factors
Amina Amadou, Gabriela Torres-Mejía, Pierre Hainaut, et al.
The Lancet. Oncology
|
September 1, 2009
Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening?
Maria Isabel Waddington Achatz, Pierre Hainaut, Patricia Ashton-Prolla
Breast Cancer Research and Treatment
|
March 12, 2010
Estrogen levels act as a rheostat on p53 levels and modulate p53-dependent responses in breast cancer cell lines
Lynnette Fernández-Cuesta, Suresh Anaganti, Pierre Hainaut, et al.
Biochemical Pharmacology
|
March 29, 2003
Activation of p53 by the cytoprotective aminothiol WR1065: DNA-damage-independent pathway and redox-dependent modulation of p53 DNA-binding activity
Olivier Pluquet, Sophie North, Marie-Jeanne Richard, et al.
International Journal of Cancer
|
June 16, 2010
p53 status influences response to tamoxifen but not to fulvestrant in breast cancer cell lines
Lynnette Fernandez-Cuesta, Suresh Anaganti, Pierre Hainaut, et al.
Cancer Letters
|
August 18, 2009
Worldwide genetic diversity of HBV genotypes and risk of hepatocellular carcinoma
Flor Helene Pujol, Maria-Cristina Navas, Pierre Hainaut, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 16, 2010
The European Prospective Investigation into Cancer and Nutrition biobank
Pierre Hainaut, Béatrice Vozar, Sabina Rinaldi, et al.
Gastroenterology
|
June 16, 2009
In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure
Ahmad Besaratinia, Sang-In Kim, Pierre Hainaut, et al.
Cell Death and Differentiation
|
November 24, 2023
Exploring the genetic and molecular basis of differences in multiple myeloma of individuals of African and European descent
Arnold J Levine, John D Carpten, Maureen Murphy, et al.
BMC Cancer
|
March 22, 2013
Effects of Δ40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53
Hind Hafsi, Daniela Santos-Silva, Stéphanie Courtois-Cox, et al.
Page
of 28